Paris, France

Claude Desgranges


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2005-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Claude Desgranges: Innovator in Hepatitis C Research

Introduction

Claude Desgranges is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the development of antibodies for the treatment of hepatitis C virus (HCV) infections. With a total of two patents to his name, Desgranges has demonstrated a commitment to advancing healthcare through innovative solutions.

Latest Patents

Desgranges' latest patents focus on the development of novel antibodies that specifically recognize conformation-dependent epitopes of the HCV glycoprotein E2. These antibodies are capable of neutralizing the binding of the E2 protein onto susceptible cells. His patents also detail the antigens and epitopes recognized by these antibodies, as well as the polynucleotides encoding them. Furthermore, the patents provide vectors comprising these polynucleotides and host cells transformed with them, which are used in the production of the antibodies. In addition, pharmaceutical and diagnostic compositions are included, which comprise the aforementioned antibodies, antigens, epitopes, polynucleotides, vectors, or cells. The use of these antibodies, antigens, polynucleotides, and vectors in adoptive immunotherapy is also described, particularly for the treatment or prevention of HCV infection during liver transplantation.

Career Highlights

Throughout his career, Desgranges has worked with prominent organizations such as Genmab and the Institut National de la Santé et de la Recherche Médicale. His work in these institutions has allowed him to contribute to groundbreaking research in the field of immunotherapy and infectious diseases.

Collaborations

Desgranges has collaborated with esteemed colleagues, including Christian Reiter and François Habersetzer. These partnerships have further enriched his research and development efforts in the medical field.

Conclusion

Claude Desgranges is a distinguished inventor whose work in hepatitis C research has the potential to significantly impact the treatment and prevention of this viral infection. His innovative patents and collaborations highlight his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…